In order to assert itself as a privileged partner of the big names in the pharmaceutical industry, Solabia has been able to take advantage of its complementary know-how as well as the quality of its production units that meet the constraints of the pharmacopoeia, to offer high-performance products that meet the expectations of the market.
The Pharmaceutical Division of the Solabia group offers a range of innovative active ingredients recognized for their health benefits, whether they are of animal origin (Chondroitin sulfate), biotechnology or fine chemistry (PCA and derivatives).
Solabia Pharma is positioned as one of the leading manufacturers of Magnesium Pidolate and Chondroitin Sulfate at the international level.
The objective of the Pharmaceutical Division of the Solabia Group is to provide its various customers with quality ingredients of high standards while adopting a global approach that promotes respect for the environment and an internal policy based on continuous improvement.
The Solabia group attaches particular importance to developing partnerships with its customers. Closer to their needs, its marketing and R&D teams offer turnkey concepts to initiate their new projects and formulation advice to help them in the implementation and positioning of its ingredients.
